October 5, 2015November 5, 2015

Anthera Pharmaceuticals Announces Start of Cystic Fibrosis Patient Recruitment For SOLUTION Clinical Trial

Cystic Fibrosis, News

Anthera Pharmaceuticals, Inc. announced that it is actively recruiting participants for its new Phase 3 clinical study on Cystic Fibrosis, called SOLUTION (Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin). ... Read more

March 26, 2015November 5, 2015

CFFT Grants $3 Million to Anthera’s CF-Related Pancreatic Insufficiency Treatment

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) has awarded biopharmaceutical company Anthera Pharmaceuticals, Inc. a $3 million grant to help accelerate the development and clinical study of the company’s new pancreatic enzyme replacement therapy. The investigative therapeutic option called Sollpura (liprotamase) is ... Read more